INS and Hypoglycemia: In addition, the increased use of basal-bolus regimens and the preference for newer insulins with more physiologic profiles and lower risk of hypoglycemia may also have contributed to these results, namely for the reduction in episodes of hypoglycemia observed during hospitalization.